About 10 new cases of ruptured aneurysm per 100,000 population may be anticipated each year. The average age of such patients is just over 50 years. While 15 or 20 % of sufferers die instantly the majority now survive to be hospitalized. If these patients do not die of the initial disruptive effects of their hemorrhage they then have to face a variety of life threatening delayed hazards including most importantly delayed ischemia from chronic vasospasm as well as rebleeding. It has been estimated that an effective therapy for vasospasm could save 5,000 lives in North America per year. In the past decade there has been progress in the medical management of the low blood flow resulting from the spasm of the larger basal conducting arteries consequent to the surrounding clot. Firstly, regional flow is increased by ensuring optimal circulating blood volume, hematocrit, pressure, viscosity and cardiac output. Secondly, neurological outcome has been improved by the use of calcium antagonists which operate by a mechanism other than the prevention of vasospasm in the large conducting arteries-they may dilate smaller vessels or provide an element of direct neuronal protection. These developments have not however directly attacked the basic problem of cerebral vasospasm. The pathophysiological chain of events and its biochemical correlates are largely unknown so that rational, direct therapy or prophylaxis is difficult. While complete removal of the inciting blood clot wihin 48 hours prevents vasospasm from developing in the primate model, total removal is not possible in patients and vigorous attempts at this carries additional surgical risks. A pharmacological intervention to halt the chemical reactions which ultimately lead to a spastic arterial segment would be preferable to the surgical prophylaxis if it were without significant side effects such as systemic hypotension. It is proposed to characterize the chemical, pharmacological and physiological changes associated with the development of chronic vasospasm in a primate model using direct clot application to the surgically exposed basal vessels sand sequential sampling of arteries and brain tissue. Treatment strategies will be applied as the mechanism is elucidated and as new and promising drugs and delivery techniques are introduced.
| Jahromi, Babak S; Aihara, Yasuo; Ai, Jinglu et al. (2008) Temporal profile of potassium channel dysfunction in cerebrovascular smooth muscle after experimental subarachnoid haemorrhage. Neurosci Lett 440:81-6 |
| Aihara, Yasuo; Jahromi, Babak S; Yassari, Reza et al. (2008) Induction of housekeeping gene expression after subarachnoid hemorrhage in dogs. J Neurosci Methods 172:1-7 |
| Sabri, Mohammed; Kawashima, Ayako; Ai, Jinglu et al. (2008) Neuronal and astrocytic apoptosis after subarachnoid hemorrhage: a possible cause for poor prognosis. Brain Res 1238:163-71 |
| Jahromi, Babak S; Aihara, Yasuo; Ai, Jinglu et al. (2008) Voltage-gated K+ channel dysfunction in myocytes from a dog model of subarachnoid hemorrhage. J Cereb Blood Flow Metab 28:797-811 |
| Rosengart, Axel J; Schultheiss, Kim E; Tolentino, Jocelyn et al. (2007) Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke 38:2315-21 |
| Xie, An; Aihara, Yasuo; Bouryi, Vitali A et al. (2007) Novel mechanism of endothelin-1-induced vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 27:1692-701 |
| Nikitina, Elena; Zhang, Zhen-Du; Kawashima, Ayako et al. (2007) Voltage-dependent calcium channels of dog basilar artery. J Physiol 580:523-41 |
| Fergusen, Sherise; Macdonald, R Loch (2007) Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 60:658-67;discussion 667 |
| Rosen, David S; Amidei, Chris; Tolentino, Jocelyn et al. (2007) Subarachnoid clot volume correlates with age, neurological grade, and blood pressure. Neurosurgery 60:259-66;discussion 266-7 |
| Weyer, George W; Jahromi, Babak S; Aihara, Yasuo et al. (2006) Expression and function of inwardly rectifying potassium channels after experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 26:382-91 |
Showing the most recent 10 out of 67 publications
